Viridian Therapeutics (VRDN) Short Interest
Nasdaq • VRDN • US92790C1045
As of Oct 22, 2026, ORTEX estimated 16.4% of free float sold short, 7.9 days to cover, cost to borrow 0.52%. Sign up for live short interest data.
Nasdaq • VRDN • US92790C1045
As of Oct 22, 2026, ORTEX estimated 16.4% of free float sold short, 7.9 days to cover, cost to borrow 0.52%. Sign up for live short interest data.
This page tracks how heavily Viridian Therapeutics (Nasdaq:VRDN) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Viridian Therapeutics (Nasdaq: VRDN) has a market capitalization of $3.23B. Last close $28.49 (as of 2026-11-09); 52-week range $13.18 to $34.29. ORTEX data as of 2026-10-22: short interest was 16.39% of free float, 7.9 days to cover and the average cost to borrow was 0.52%. Sign up for live short interest data.